Another report by Guodong X et al. indicated that FBXW7 could interact with Snai1 in NSCLC cell lines and directly degrade its expression, resulting in suppression of cisplatin and sorafenib resistance (Guodong et al., 2018). This evidence concerns the gene FBXW7 and non-small cell lung carcinoma.